How I Contracted HIV Is None of Your Damn Business
By Toraje Heyward How I contracted HIV is none of your damn business. I’m going to tell you what happened, but not because I owe you an explanation. Here goes.
By Toraje Heyward How I contracted HIV is none of your damn business. I’m going to tell you what happened, but not because I owe you an explanation. Here goes.
| Sure most HIV advocates have heard of U=U, but how do we get the rest of the world to listen? By Desiree Guerrero For about the past decade, activists
| The Office of HIV and AIDS Malignancy at the National Cancer Institute coordinates cancer and HIV research. By Oriol R. Gutierrez Jr. Robert Yarchoan, MD, is the director of
By Theo Smart When the dashing and magnificently bearded Dr. Giovanni Guaraldi took to the stage at last fall’s HIV and Aging conference in New York City, and described a
| How drag queens are becoming the heroes of HIV prevention By Desiree Guerrero My love affair with drag queens goes way back. Since my childhood in the suburbs of
|That Has to Change By Tyunique Nelson As a young person who identifies as nonbinary, meaning I do not identify within the gender binary, accessing pre-exposure prophylaxis (PrEP) was a
By Michael Lamb The day the universe decided it wanted to see sugar, spice and everything nice, it was June 10, 1991 – the day I was born. Even as
It’s been another tumultuous year, but at least in 2018 we started talking about HIV again By Desirée Guerrero Let’s face it, it’s been a rough one. More senseless shootings,
| Why people living and aging with HIV will lead the way By Jeff Berry Long-term survivors of HIV face unique challenges – they are the “hidden” survivors of the
When it comes to HIV disclosure, it’s time to stop involving the police By Kenyon Farrow When I see films or documentaries about the early days of the AIDS epidemic
Almost a quarter-century after his passing, Pedro Zamora continues to inspire future generations and help in the fight against HIV By Desirée Guerrero I recently had the honor of
Understanding the importance of basic HIV research and clinical trials – and the benefits of being undetectable By Oriol R. Gutierrez Jr. Carl W. Dieffenbach, PhD, is director of the Division